首页> 外国专利> Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism

Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism

机译:解淀粉芽孢杆菌 K317用于抑制耐药性病原微生物或肠道致病微生物的生长

摘要

The present invention relates to a Bacillus amyloliquefaciens K317 strain suppressing the growth of antibiotics-resistant pathogenic microorganisms or enteropathogenic microorganisms, more precisely a Bacillus amyloliquefaciens K317 strain, a culture supernatant thereof and an antibacterial metabolite separated from the same. The Bacillus amyloliquefaciens K317 strain, the culture supernatant thereof and the antibacterial metabolite separated from the same of the invention can be effectively used for the composition, health food, and probiotics for inhibiting the growth of antibiotics-resistant pathogenic microorganisms and enteropathogenic microorganisms, since they have excellent antibacterial activity and inhibition effect on the growth of methicillin resistant pathogenic microorganism and such enteropathogenic microorganism as Edwardsiella tarda, E. coli and Staphylococcus epidermidis.
机译:本发明涉及抑制抗生素抗性病原性微生物或肠致病性微生物的生长的解淀粉芽孢杆菌K317菌株,更准确地说,是一种解淀粉芽孢杆菌K317菌株,其培养上清液和与之分离的抗菌代谢物。淀粉芽孢杆菌K317菌株,其培养上清液和从其分离的抗菌代谢物可以有效地用于组合物,保健食品和益生菌,以抑制抗药性致病菌的生长。微生物和肠致病性微生物,因为它们具有优异的抗菌活性和对耐甲氧西林的致病性微生物以及肠致病性微生物(如埃德华氏菌,大肠杆菌表皮葡萄球菌)的生长的抑制作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号